Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

SIMPLE SUMMARY: The only vaccine approved by FDA as a treatment for cancer is sipuleucel-T, a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). Most investigators studying anti-tumor vaccines believe they will be most effective as parts of combination therapies, rath...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamat-Huber, Melissa, Jeon, Donghwan, Johnson, Laura E., Moseman, Jena E., Muralidhar, Anusha, Potluri, Hemanth K., Rastogi, Ichwaku, Wargowski, Ellen, Zahm, Christopher D., McNeel, Douglas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601088/
https://www.ncbi.nlm.nih.gov/pubmed/33008010
http://dx.doi.org/10.3390/cancers12102831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601088/
https://www.ncbi.nlm.nih.gov/pubmed/33008010
http://dx.doi.org/10.3390/cancers12102831

Ejemplares similares